ESPERION THERAPEUTICS INC/MI
S-1/A, EX-27.1, 2000-07-10
PHARMACEUTICAL PREPARATIONS
Previous: ESPERION THERAPEUTICS INC/MI, S-1/A, EX-23.1, 2000-07-10
Next: ESPERION THERAPEUTICS INC/MI, S-1/A, EX-27.2, 2000-07-10



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ESPERION
THERAPEUTICS, INC.'S DECEMBER 31, 1998 AND DECEMBER 31, 1999 FINANCIAL
STATEMENT AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-31-1999
<PERIOD-START>                             MAY-18-1998             JAN-01-1999
<PERIOD-END>                               DEC-31-1998             DEC-31-1999
<CASH>                                      12,540,963               5,903,932
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                            12,616,831               6,042,934
<PP&E>                                         864,496               2,427,554
<DEPRECIATION>                                  67,619                 471,622
<TOTAL-ASSETS>                              13,413,708               7,998,866
<CURRENT-LIABILITIES>                          226,864               2,900,382
<BONDS>                                              0               2,283,781
                                0                       0
                                    105,000                 105,000
<COMMON>                                         1,705                   1,936
<OTHER-SE>                                  15,302,157              16,466,806
<TOTAL-LIABILITY-AND-EQUITY>                13,413,708               7,998,886
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                             2,387,002              11,002,028
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                             243,939                 331,844
<INCOME-PRETAX>                            (2,143,063)            (10,670,184)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (2,143,063)            (10,670,184)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (2,143,063)            (10,670,184)
<EPS-BASIC>                                     (1.46)                  (5.91)
<EPS-DILUTED>                                   (1.46)                  (5.91)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission